Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.510
+0.070 (1.58%)
At close: Aug 24, 2026, 4:00 PM EDT
4.510
0.00 (0.00%)
After-hours: Aug 24, 2026, 4:10 PM EDT
Passage Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 24.16 | 46.3 | 37.57 | 21.71 | 34.6 | 128.97 |
Short-Term Investments | - | - | 39.18 | 92.59 | 155.01 | 186.81 |
Cash & Short-Term Investments | 24.16 | 46.3 | 76.76 | 114.29 | 189.61 | 315.77 |
Cash Growth | -58.08% | -39.67% | -32.84% | -39.72% | -39.95% | 3.59% |
Prepaid Expenses | 0.77 | 0.63 | 0.84 | 0.92 | 0.93 | 1.73 |
Other Current Assets | 0.25 | 0.83 | 1.22 | 2.74 | 6.51 | 7.57 |
Total Current Assets | 25.18 | 47.76 | 78.82 | 117.96 | 197.04 | 325.07 |
Property, Plant & Equipment | - | 14.28 | 23.13 | 32.15 | 42.24 | 23.81 |
Other Long-Term Assets | - | 0.24 | 0.46 | 0.43 | 4.27 | 6.2 |
Total Assets | 25.18 | 62.28 | 102.41 | 150.55 | 243.55 | 355.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.9 | 1.11 | 0.74 | 1.3 | 4.07 | 9.45 |
Accrued Expenses | 3.57 | 4.65 | 6.71 | 9.67 | 10.93 | 19.39 |
Current Portion of Leases | - | 3.57 | 3.69 | 3.37 | 3.28 | - |
Other Current Liabilities | 16.25 | 13.75 | 8.23 | 2 | 0.09 | 0.66 |
Total Current Liabilities | 20.72 | 23.08 | 19.36 | 16.34 | 18.35 | 29.5 |
Long-Term Leases | - | 20.44 | 21.79 | 22.92 | 23.83 | - |
Other Long-Term Liabilities | - | - | - | - | - | 6.92 |
Total Liabilities | 20.72 | 43.53 | 41.15 | 39.26 | 42.18 | 36.42 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | - | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 724.59 | 723.51 | 720.49 | 705.79 | 694.73 | 675.35 |
Retained Earnings | -720.14 | -704.76 | -659.24 | -594.47 | -492.41 | -356.28 |
Comprehensive Income & Other | - | - | 0.01 | -0.04 | -0.97 | -0.41 |
Total Common Equity | 4.46 | 18.76 | 61.26 | 111.28 | 201.37 | 318.66 |
Shareholders' Equity | 4.46 | 18.76 | 61.26 | 111.28 | 201.37 | 318.66 |
Total Liabilities & Equity | 25.18 | 62.28 | 102.41 | 150.55 | 243.55 | 355.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 24.01 | 25.48 | 26.29 | 27.11 | - |
Net Cash (Debt) | 24.16 | 22.29 | 51.28 | 88 | 162.5 | 315.77 |
Net Cash Growth | -26.57% | -56.53% | -41.73% | -45.85% | -48.54% | 3.59% |
Net Cash Per Share | 7.56 | 7.03 | 16.66 | 32.15 | 59.71 | 118.39 |
Filing Date Shares Outstanding | 3.22 | 3.21 | 3.11 | 2.78 | 2.73 | 2.71 |
Total Common Shares Outstanding | 3.22 | 3.18 | 3.1 | 2.75 | 2.73 | 2.71 |
Working Capital | 4.46 | 24.68 | 59.45 | 101.62 | 178.69 | 295.57 |
Book Value Per Share | 1.38 | 5.89 | 19.74 | 40.51 | 73.74 | 117.49 |
Tangible Book Value | 4.46 | 18.76 | 61.26 | 111.28 | 201.37 | 318.66 |
Tangible Book Value Per Share | 1.38 | 5.89 | 19.74 | 40.51 | 73.74 | 117.49 |
Machinery | - | 1.51 | 11.67 | 11.68 | 12.87 | 12.05 |
Construction In Progress | - | - | - | 0.64 | 1.29 | 0.82 |
Leasehold Improvements | - | 6.51 | 7.39 | 10.21 | 13.51 | 13.41 |